Epilepsy and speech disorders are common diseases in the Australian population that have major genetic contributions. To improve clinical care I will study our unique set of patients with epilepsies or speech impairments. Discovery of genes will provide new information that will improve diagnosis, treatment and counselling of patients and their families. This will enhance long established Australian clinical and research expertise in epilepsy and speech disorders.
Communication And Swallowing Outcomes In Patients With Acquired And Progressive Neurological Disorders
Funder
National Health and Medical Research Council
Funding Amount
$426,556.00
Summary
We all talk, eat and drink, but it’s not until we lose these skills that we recognise their importance. Communication & swallowing disorders following from progressive brain disorders such as dementia and ataxia result in daily disadvantage through poor educational and employment outcomes & social isolation. These deficits make the evaluation, long term monitoring and treatment a critical element in disease management.
The Ethics And Politics Of Pharmaceutical Innovation And Translation
Funder
National Health and Medical Research Council
Funding Amount
$476,728.00
Summary
I lead a research program on the ethics and politics of pharmaceutical innovation and translation: how medicines are developed, regulated, funded and taken up into practice. I aim to help policymakers to deal with conflicts among stakeholders. Over the next 4 years I will conduct a suite of research projects on topics of immediate significance to Australian policymakers; develop a new framework for pharmaceutical ethics and create a “Pharmaceutical Ethics and Politics Network.”